Your browser doesn't support javascript.
loading
Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020.
Aït Moussa, Latifa; Tebaa, Amina; Alj, Loubna; Sefiani, Houda; Meski, Fatima Zahra; Khattabi, Asmae; Soulaymani Bencheikh, Rachida.
  • Aït Moussa L; Department of Pharmacovigilance, Centre Anti Poison Et de Pharmacovigilance du Maroc, Rue Lamfedel Cherkaoui, Rabat-Institut, Madinat Al Irfane, BP: 6671, Rabat, 10100, Morocco. aitmoussalatifa@gmail.com.
  • Tebaa A; Morocco Field Epidemiology Training Program, Ministry of Health, Rabat, 10100, Morocco. aitmoussalatifa@gmail.com.
  • Alj L; Department of Pharmacovigilance, Centre Anti Poison Et de Pharmacovigilance du Maroc, Rue Lamfedel Cherkaoui, Rabat-Institut, Madinat Al Irfane, BP: 6671, Rabat, 10100, Morocco.
  • Sefiani H; Department of Pharmacovigilance, Centre Anti Poison Et de Pharmacovigilance du Maroc, Rue Lamfedel Cherkaoui, Rabat-Institut, Madinat Al Irfane, BP: 6671, Rabat, 10100, Morocco.
  • Meski FZ; Morocco Field Epidemiology Training Program, Ministry of Health, Rabat, 10100, Morocco.
  • Khattabi A; Department of Pharmacovigilance, Centre Anti Poison Et de Pharmacovigilance du Maroc, Rue Lamfedel Cherkaoui, Rabat-Institut, Madinat Al Irfane, BP: 6671, Rabat, 10100, Morocco.
  • Soulaymani Bencheikh R; Morocco Field Epidemiology Training Program, Ministry of Health, Rabat, 10100, Morocco.
Naunyn Schmiedebergs Arch Pharmacol ; 396(12): 3847-3856, 2023 12.
Article en En | MEDLINE | ID: mdl-37358793

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article